Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4aa5 | NQB | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.685 | |
| 4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.662 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.649 | |
| 4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.615 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.600 | |
| 2qd9 | LGF | Mitogen-activated protein kinase 14 | / | 0.598 | |
| 3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.595 | |
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.583 | |
| 3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.580 | |
| 2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.577 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.575 | |
| 3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.571 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.567 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.564 | |
| 2rg5 | 279 | Mitogen-activated protein kinase 14 | / | 0.556 | |
| 4kin | 1M8 | Mitogen-activated protein kinase 14 | / | 0.552 | |
| 4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.547 | |
| 1zz2 | B11 | Mitogen-activated protein kinase 14 | / | 0.544 | |
| 3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.544 | |
| 2rg6 | 287 | Mitogen-activated protein kinase 14 | / | 0.543 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.543 | |
| 3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.537 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.534 | |
| 3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.534 | |
| 4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.534 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.533 | |
| 3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.532 | |
| 3ocg | OCG | Mitogen-activated protein kinase 14 | / | 0.530 | |
| 3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.525 | |
| 3hvc | GG5 | Mitogen-activated protein kinase 14 | / | 0.522 | |
| 4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.520 | |
| 3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.517 | |
| 3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.514 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.505 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.505 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.504 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.504 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.502 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.494 | |
| 3mvm | 39P | Mitogen-activated protein kinase 14 | / | 0.494 | |
| 3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.494 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.492 | |
| 3u8w | 09J | Mitogen-activated protein kinase 14 | / | 0.491 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.487 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.486 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.484 | |
| 2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.484 | |
| 3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.481 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.480 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.479 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.478 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.474 | |
| 2ghl | LIB | Mitogen-activated protein kinase 14 | / | 0.472 | |
| 3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 0.471 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.470 | |
| 1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 3mwu | BK3 | Calmodulin-domain protein kinase 1, putative | / | 0.465 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.465 | |
| 1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.464 | |
| 2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
| 4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.464 | |
| 1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.463 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.463 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.463 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.463 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.463 | |
| 4kbc | 1QJ | Casein kinase I isoform delta | 2.7.11.1 | 0.463 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.463 | |
| 3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.460 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.460 | |
| 4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.460 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.459 | |
| 3bv3 | P39 | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 3gc7 | B45 | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 4eh7 | 0OO | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.456 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
| 2vyn | NAD | Glyceraldehyde-3-phosphate dehydrogenase A | / | 0.454 | |
| 3fmn | 530 | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.453 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.453 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.452 | |
| 4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.451 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.451 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.449 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.449 | |
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.447 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.446 | |
| 1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.445 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.445 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.445 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.445 | |
| 4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.445 | |
| 1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.444 | |
| 3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.444 | |
| 3uzp | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.444 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.444 | |
| 2gtn | LIE | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.443 | |
| 4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.443 | |
| 1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.442 | |
| 2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.442 | |
| 3dga | NDP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.442 | |
| 4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
| 3lfe | Z84 | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.441 | |
| 1ywn | LIF | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.440 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.440 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.440 |